Sam Tomlinson, Vice President of Global Drug Safety at Arriello unpacks North America/EU research which compares today’s commercialisation strategies with those of five years ago. As biotechs around the world look to new territories including emerging markets for their next returns, many are encountering unexpected hurdles. Too… Read More
The DDW Turning Science into Business Symposium will take place in the afternoon on Tuesday 4 November 2025 at the Francis Crick Institute, one of Europe’s biggest biomedical labs, in London, UK. This is a half day conference and will include a coffee/networking break. Speakers from Cancer… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Our news round-up this week focuses on start-ups, the innovative fledgling companies that are… Read More
News round-up for 3-7 March by DDW Senior Digital Content Editor Diana Spencer. Our news round-up this week focuses on start-ups, the innovative fledgling companies that are coming through and sparking new life into various areas of drug discovery. The top stories: Start-up… Read More
Sphere Fluidics has announced it is rebranding to Sphere Bio to reflect the company’s transition from a focus on droplet-based microfluidics to a provider of integrated life sciences tools and solutions. Founded in 2010, the company has been focused on the development of novel single-cell analysis products… Read More
The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Our news round-up at the end of last year focused on drug… Read More
News round-up for 6-10 January by DDW Senior Digital Content Editor Diana Spencer. Our news round-up at the end of last year focused on drug discovery investment, so it is positive to see that this has also started strong in 2025, with a number of new acquisitions, research… Read More
The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. As we approach the end of 2024, it’s great to see that… Read More
News round-up for 16-20 December by DDW Senior Digital Content Editor Diana Spencer. As we approach the end of 2024, it’s great to see that investment in drug discovery is still going strong, with an impressive $300 million raised by AI-focused company SandboxAQ and another significant financing by… Read More
BenevolentAI has unveiled a major strategic overhaul, which it says will return the company to its founding TechBio mission. The company has initiated significant organisational and budgetary changes that extend into 2027 and is also exploring options to delist from Euronext Amsterdam. Kenneth Mulvany, Executive… Read More
The latest collaborations within drug discovery will focus on drug combinations, antibodies, nanovesicles, and organ-on-a-chip technology to advance the treatment of sarcopenia, and cardiovascular, kidney and genetic diseases. IsomAb and Catalent Biotechnology company IsomAb and Catalent have entered a strategic collaboration, which includes development of ISM-001… Read More
Half of the 2023 US pharmaceutical launch class underperformed their pre-launch first year forecast while 39% overperformed. However, this is an improvement from prior years, with 54% underperforming and 35% overperforming when evaluating new product launches in the US from 2020-2023. These are the… Read More
This is the latest episode of the free DDW narrated podcast, titled “How to streamline regulatory approval”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Quicker time to regulatory submission through improved data management and The… Read More
Turnstone Biologics has announced a “strategic prioritisation of its pipeline”, as well as a workforce reduction of approximately 60% and changes to its leadership team. The cuts are designed to allow the company to focus resources on the continued advancement of its Phase I programme, selected… Read More
Science and innovation campus, Discovery Park, in Sandwich, UK, has launched applications for the third stage of its business growth competition, ‘Discovery Spark’. The programme aims to equip early-stage life science and technology companies with business skills and tools, refine their commercial strategy and achieve investor… Read More
Closed Loop Medicine has joined the NVIDIA Inception accelerator programme, designed to nurture start-ups and early-stage companies revolutionising industries with technological advancements. The programme supports all stages of a start-up’s life cycle, providing access to the latest tools, expertise, and a network of venture capitalist investors,… Read More
